secwatch.observer — SEC 8-K summary
======================================

Issuer:     RxSight, Inc. (RXST)
CIK:        0001111485
Form:       8-K
Filed at:   2025-04-03T23:59:59+00:00
Accession:  0000950170-25-049797
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

RxSight preliminary Q1 revenue $37.9M (+28% YoY); cuts FY2025 guidance to $160M-$175M
--------------------------------------------------------------------------------

- Preliminary Q1 2025 revenue ~$37.9M, up 28% YoY but down 6% QoQ; LAL procedure volume 27,579 (+36% YoY).
- LDD installed base reached 1,044 as of March 31, 2025, a 43% increase from 732 a year earlier.
- FY2025 revenue guidance lowered to $160M-$175M (from $185M-$197M); operating expense guidance cut to $150M-$160M.
- Stock-based compensation expected to be $27M-$30M, up from prior $22M-$25M; cites premium IOL market headwinds.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1111485/000095017025049797/0000950170-25-049797-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1111485/000095017025049797/rxst-20250402.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-049797

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer